SCHEMBL19852352

SCHEMBL19852352

CCC1(CCN)CCc2ccccc2O1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.40
HTR2A P28223 3/20 0.38
DRD2 P14416 2/20 0.38
HTR2C P28335 2/20 0.35
KCNH2 Q12809 1/20 0.35
CYP2D6 P10635 2/20 0.35
TSHR P16473 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP1A2 P05177 1/20 0.35
PKM P14618 1/20 0.35
NFKB1 P19838 1/20 0.35
THPO P40225 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NISCH Q9Y2I1 1/20 0.35
MEN1 O00255 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7440977 0.87 SIGMAR1 (0.45) SIGMAR1HTR2ADRD2HTR2CKCNH2
SCHEMBL8970282 0.82 SIGMAR1 (0.40) SIGMAR1HTR2ADRD2HTR2CKCNH2
SCHEMBL19289692 0.81 SIGMAR1 (0.43) SIGMAR1HTR2ADRD2HTR2CKCNH2
SCHEMBL8426777 0.77 TRPM8 (0.42) SIGMAR1HTR2ADRD2CYP2D6TSHR
SCHEMBL8038088 0.74 TSHR (0.43) SIGMAR1HTR2ACYP2D6TSHRCYP2C19
SCHEMBL1797048 0.74 SIGMAR1 (0.43) SIGMAR1HTR2ADRD2HTR2CKCNH2
SCHEMBL15075010 0.74 SIGMAR1 (0.45) SIGMAR1HTR2ADRD2HTR2CKCNH2
SCHEMBL11256078 0.72 SIGMAR1 (0.44) SIGMAR1HTR2ADRD2HTR2CKCNH2
SCHEMBL7439505 0.71 SIGMAR1 (0.43) SIGMAR1HTR2ADRD2HTR2CKCNH2
SCHEMBL6921400 0.71 SIGMAR1 (0.43) SIGMAR1HTR2ADRD2HTR2CKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026371-A1 DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS SUNOVION PHARMACEUTICALS INC. (US) 2018-02-08 WO disclosed